Cervical cancer is the second major malignant tumor in women [1] , half a million women are diagnosed as having cervical cancer each year in the world, leading to 9% of the deaths in women [2] . Pelvic lymph node metastasis is the major risk factor which affects the prognosis of cervical cancer patients. The pelvic lymph node metastasis rate in stage IBIIB cervical cancer is reported to be 15%31% [35] . Once pelvic lymph node metastasis occurs, the 5year overall survival rate reaches approximately 30%60% [6] . The probability of common iliac lymph node metastasis is relatively low in pelvic lymph node metastasis, but once it happened, the survival rate of the patients would decrease significantly [5,6] . However, few systematic studies on characteristics, risk factors, treatment and prognosis of common iliac lymph node metastasis have been reported. Here, through retrospective study, we systematically analyzed clinical and pathological data of 960 patients with IBIIB cervical cancer receiving radical hysterectomy and explored the characteristics, related risk factors, treatment and prognosis of patients with common iliac lymph node metastasis.
Cervical cancer is the second major malignant tumor in women [1] , half a million women are diagnosed as having cervical cancer each year in the world, leading to 9% of the deaths in women [2] . Pelvic lymph node metastasis is the major risk factor which affects the prognosis of cervical cancer patients. The pelvic lymph node metastasis rate in stage IBIIB cervical cancer is reported to be 15%31% [35] . Once pelvic lymph node metastasis occurs, the 5year overall survival rate reaches approximately 30%60% [6] . The probability of common iliac lymph node metastasis is relatively low in pelvic lymph node metastasis, but once it happened, the survival rate of the patients would decrease significantly [5, 6] . However, few systematic studies on characteristics, risk factors, treatment and prognosis of common iliac lymph node metastasis have been reported. Here, through retrospective study, we systematically analyzed clinical and pathological data of 960 patients with IBIIB cervical cancer receiving radical hysterectomy and explored the characteristics, related risk factors, treatment and prognosis of patients with common iliac lymph node metastasis.
A total of 960 patients with IBIIB stage cervical cancer who received radical treatment in gynecologic surgery from January 1995 to December 2005 in the Cancer Center of Sun Yetsen University were studied. Fortyfive cases were recruited with the following conditions: (1) IBIIB stage according to international federation of gynecologists & obstetricians (FIGO) stage; (2) 窑 Clinical Research窑 underwent a wide range hysterectomy and pelvic lymph node dissection; (3) diagnosed as cervical invasive carcinoma with common iliac lymph node metastasis; and (4) with complete postoperative followup information.
The average age of the 45 patients was 45 years, with a median age of 44 years (2556 years). According to FIGO diagnostic criteria in 1995, 16 cases had stage IB (35.6% ) cervical cancer, 10 cases IIA (22.2% ), 19 cases IIB (42.2% ), 39 (86.7% ) cases had squamous cell carcinoma and 6 (13.3% ) cases had adenocarcinoma. The metastasis rate was 4.7% (45/960), accounting for 15.6% (45/288) of pelvic lymph node metastasis.
High risk factors related to common iliac lymph node metastasis of cervical cancer were selected for analysis, such as age, serum SCCAg level before treatment, clinical stage, histological grade, tumor size, histological type, depth of cervical invasion, cervical canals invasion, parametrial margin, vaginal margin, the group number of positive pelvic lymph nodes metastasis (excluding iliac lymph node metastasis) and postoperative adjuvant treatment.
In 45 patients with common iliac lymph node metastasis, 8 (17.8%) refused postoperative adjuvant treatment and 37 (82.2% ) underwent postoperative adjuvant treatment. Among these 37 patients, 13 received radiotherapy, 7 received chemotherapy and 17 received combined radiotherapy and chemotherapy. CBP adjuvant chemotherapy program was used (CTX (cyclophosphamide) + BLM (bleomycin) + Carbo). Seven cases received radical surgery and bilateral pelvic arterial chemotherapy through Carbo simultaneously, and additional BLM and CTX after radical surgery.
Out鄄 patient clinic review, telephone calls and letter correspondence were used for followup. The followup was started from the day of pathological diagnosis. The overall survival (OS) time was calculated from surgery to death. The progression free survival (PFS) time was calculated from surgery to recurrence or death. The deadline of followup was November 15, 2009 and the followup rate was 93.4% (897/960) with a median followup time of 62 months (1140 months).
Statistical analysis was performed using SPSS. 字 2 test was used for univariate analysis of classification variables; Logistic regression was used for multivariate analysis; KaplanMeier method was used for statistics of 5year overall survival rate and comparison of survival curve; and Logrank test was used for survival rate comparison.
Among 960 IBIIB stage cervical carcinoma patients with common iliac lymph node metastasis, 288 patients (30.0%) had pelvic lymph node metastasis. Fortyfive (4.7% ) patients had common iliac lymph node metastasis. The general distribution characteristics of lymph node metastasis were as follows: 196 cases (20.4% , 196/960) had obturator lymph node metastasis, 63 (6.6% , 63/960) had internal iliac lymph node metastasis, 68 (7.1% , 68/960) had external iliac lymph node metastasis, 45 (4.7% , 45/960) had common iliac lymph node metastasis, 17 (1.8% , 17/960) had inguinal lymph node metastasis and 18 (1.9% , 18/960) had peritoneal paraaortic lymph node metastasis (Table 1, Figure 1 ).
The pelvic lymph node metastasis distribution of the 45 patients complicated with common iliac lymph node metastasis was as follows: 8 cases (17.8% ) had solitary iliac lymph node metastasis and 37 (82.2% ) had multiple lymph node metastasis, including 21 (46.7% ) of obturator lymph node要internal iliac lymph node/external iliac lymph node要common iliac lymph node metastasis, 6 cases (13.3%) of internal iliac lymph node/external iliac lymph node要common iliac lymph node metastasis and 10 cases (22.2% ) of obturator lymph node要common iliac lymph node metastasis. Complicated obturator lymph node metastasis occurred in 21 patients, internal iliac lymph node metastasis in 18 patients, external iliac lymph node metastasis in 22 patients, inguinal lymph node metastasis in 5 patients and peritoneal para要aortic lymph node metastasis in 4 patients. Twentyone cases had continuous metastasis through lymphatic drainage pattern (obturator lymph node要internal iliac lymph node/external lymph node要common iliac lymph node), 24 cases had jumping lymph node metastasis (6 cases of internal/external iliac lymph node要common iliac lymph node metastasis, 10 cases of obturator lymph node要common iliac lymph node metastasis and 8 cases of solitary metastasis in common iliac lymph node).
Univariate analysis of the clinical and pathological characteristics of 45 patients with common iliac lymph node metastasis showed that clinical stage, serum level of squamous cell carcinoma antigen (SCCAg) > 4 滋 g/L before treatment, depth of cervical invasion 逸 2/3 and positive margin in parametrium were associated with common iliac lymph node metastasis ( < 0.05), other factors such as age, pathological grade, tumor size, pathologic histology types, cervical canals invasion and vaginal margin showed no statistical significance ( > 0.05) between the two groups as shown in Table 1 . Multivariate analysis was performed by Logistic regression model, and the results showed that only SCCAg > 4 滋 g/L before treatment ( = 0.026, OR = 2.303) and positive margin in parametrium ( = 0.045, OR = 2.634) were the independent risk factors of common iliac lymph node metastasis ( Table 2) .
As displayed by KaplanMeier method, the 5year overall survival rates of groups of nonpelvic lymph node metastasis, pelvic lymph node metastasis (excluding iliac lymph node metastasis) and common iliac lymph node metastasis were 91.5% , 67.5% and 46.1% , respectively (Figure 2 ). There was statistical significance in the 5year overall survival rates between groups with no lymph node metastasis group and common iliac lymph node metastasis ( < 0.001) while there were significant differences in the 5year overall survival rates of patients with pelvic lymph node metastasis (excluding common iliac lymph node metastasis) and common iliac lymph node metastasis ( = 0.029).
The difference was significant between pelvic lymph node metastasis (excluding common iliac lymph node metastasis) < 3 groups and pelvic lymph node metastasis (excluding common iliac lymph node metastasis) 逸 3 groups ( < 0.001) in 45 cervical carcinoma patients with common iliac lymph node metastasis ( Figure 3 ). Nonrecurrence group and recurrence group also had significant differences ( = 0.004), as shown in Figure 4 . Thirtyseven (82.2% ) of 45 patients received postoperative adjuvant treatment (13 cases of radiotherapy, 7 cases of chemotherapy and 17 cases of combined radiotherapy and chemotherapy), and 8 (17.8% ) patients refused adjuvant treatment. The 5year overall survival rates of radiotherapy group after surgery, chemotherapy group, combined radiotherapy and chemotherapy group and nontreatment group were 38.9% , 42.9% , 39.2% and 37.5% , respectively, without significant difference ( > 0.05).
Lymph node metastasis is the main factor affecting the prognosis of cervical carcinoma, and the patients with pelvic lymph node metastasis have a poor prognosis. Monk [3] reported that the 5year overall survival rate of patients with nonlymph node metastasis was 85%90%, and ours was 91.2% .
Patients with solitary lymph node metastasis had longer survival period than with multiple lymph node metastasis. In stage III cervical carcinoma, the 5year overall survival rate of lymph node positive patients was reported to be 52.0%62%
[5] compared with 57.4% of our data, the common iliac lymph node metastasis rate was 2.0% 9.1% in stage III cervical carcinoma [1, 2] , and was 4.7% in our data. The 5year overall survival rate of patients with common iliac lymph node metastasis was 25% 47.8% [5, 7] , and ours was 46.1%. These results indicated that all our results were identical to previous studies. The prognosis of cervical carcinoma patients with common pelvic lymph node metastasis became poorer significantly. Therefore, before treating patients with common iliac lymph node, it is necessary to judge the status of the patients and evaluate the metastasis risk with comprehensive consideration of the tumor markers, clinical and pathological Figure 4 Overall survival of cervical cancer patients with or without recurrence characteristics for the best selection of treatment strategy and improvement of the 5year overall survival rate. Due to the low common iliac lymph node metastasis rate of cervical carcinoma, few studies about the related high risk factors of the common iliac lymph node metastasis have been reported. We found that clinical stage, SCCAg > 4 滋 g/L before treatment, depth of cervical invasion > 2/3 and positive margin in parametrium were associated with common iliac lymph node metastasis through univariate analysis, while through multiple analysis, we found that only SCCAg >4 滋 g/L before treatment, depth of cervical invasion > 2/3 and positive margin in parametrium were the independent risk factors in the common iliac lymph node metastasis. SCCAg is one of the most thoroughly studied indicators of lymph node metastasis related tumor markers. Takeshima [8] have indicated that the value of SCCAg was defined as 4 滋 g/L, the sensitivity and the specificity of lymph node metastasis judgment were 59.1% and 93.9% , and the positive and negative prediction values were 65.0% and 92.2% , respectively. Once SCCAg was higher than 4 滋 g/L, the risk of lymph node metastasis increased by 8.4 folds. Feng [9] found that the risk increased by 4.2 folds. Our data showed that common iliac lymph node metastasis rate of cervical carcinoma patients with serum SCCAg > 4 滋 g/L before treatment was 12.2% , which was much higher than the metastasis rate of patients with serum SCCAg 臆 4 滋 g/L before treatment (3.8% ). The common iliac lymph node metastasis risk of patients with SCCAg > 4 滋 g/L before treatment was 2.3 times that of patients with SCCAg 臆 4 g/L, suggesting that 4 滋 g/L is of great significance in evaluating the risk of common iliac lymph node metastasis. Thus, rapid pathological section should be performed for the suspected metastatic lymph node of patients with SCCAg > 4 滋 g/L, if the results were positive, biopsy taking or peritoneal paraaortic lymph node removal is necessary, which avoided unnecessary removal of lymph node and misdiagnosis of lymph node metastasis, and improved the prognosis of patients. In addition, we found that positive margin in parametrium was also an independent risk factor of common iliac lymph node metastasis. The rate of common iliac lymph node metastasis in cervical carcinoma patients with negative or positive margin in parametrium was 2.9% and 18.5% , respectively, and the risk of positive patients was 2.6 times higher than negative patients. Therefore, patients with positive margin in parametrium shown by frozen biopsy, pelvic lymph node and high peritoneal aortic lymph node should be removed, and radical laparotomy of cervical cancer type III, but not type II or other extended hysterectomy should be performed.
The patients with a pelvic lymph node metastasis 逸 3 and recurring common iliac lymph node metastasis showed poor prognosis in univariate analysis. The 5year overall survival rates of common iliac lymph node metastasis patients with a pelvic lymph node metastasis (excluding common iliac lymph node metastasis) < 3, common iliac lymph node metastasis patients with a pelvic lymph node metastasis (excluding common iliac lymph node metastasis) 逸 3, and the common iliac lymph node metastasis in the nonrecurrent group , and recurrent group were 67.7% , 37.0% , 59.7% and 16.4% , respectively. Therefore, for common iliac lymph node metastasis patients with a pelvic lymph node metastasis (excluding common iliac lymph node metastasis) 逸 3, we suggested that more appropriate treatment strategy should be selected in order to improve the survival rate. Chen . reported that postoperative adjuvant treatment raised the 5year overall survival rate of cervical carcinoma patients with pelvic lymph node metastasis [10] . However, in our 45 cases of cervical carcinoma with common iliac lymph node metastasis, postoperative adjuvant treatments did not significantly increasethe 5year overall survival rate of patients. The 5year overall survival rates of postoperational radiotherapy group, chemotherapy group, the combined radiotherapy and chemotherapy group and nontreatment group were 38.9% , 42.9%, 39.2% and 37.5%, respectively, no significant differences were found among these four groups ( > 0.05). Thus, the postoperative adjuvant treatment strategy for the cervical carcinoma patients with common iliac lymph node metastasis needed to be further studied. Perspective studies for searching more appropriate treatment strategy are also necessary to improve the prognosis of these patients. The small number of patients in our study may lead to bias in data analysis, therefore, sample size needed to be enlarged for further studies so as to draw a more accurate conclusion.
